In vivo tumor imaging using polo-box domain of polo-like kinase 1 targeted peptide.

Abstract	Polo-like kinase 1 (Plk1) is a regulator of cell cycle progression during mitosis; it is overexpressed in many different tumors and has been implicated as a potential antimitotic target. Plks are characterized by the presence of a highly conserved C-terminal polo-box domain (PBD) that is involved in regulating kinase activity. The phosphopeptide Pro-Leu-His-Ser-p-Thr (PLHSpT) is a potent selective inhibitor of the PBD of human plk1 that acts by inducing mitotic arrest and apoptotic cell death in cancer cells. We synthesized cRGDyK-S-S-CPLHSpT to exploit the drug delivery and molecular imaging using positron emission tomography (PET). The peptide was blocked dramatically proliferation of tumor in vitro and in vivo. It was attempted to develop and show a tumor PET image with the radiolabeled-peptide. Here we showed the peptide is promising not only as an anticancer drug, but also as a radioligand for tumor diagnosis with PET. We expect that our contribution will provide new insights into the design of Plk1 peptide inhibitors and have significant implications for anticancer therapy and tumor diagnosis.
Authors	Sung-Min Kim, Sunmi Yoon, Naeun Choi, Kwan Soo Hong, Ravichandran N Murugan, Gyunggoo Cho, Eun Kyoung Ryu
Journal	Biomaterials (Biomaterials) Vol. 33 Issue 29 Pg. 6915-25 (Oct 2012) ISSN: 1878-5905 [Electronic] Netherlands
PMID	22795848 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright	Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.
Chemical References	Antineoplastic Agents Cell Cycle Proteins Peptides Proto-Oncogene Proteins Protein Serine-Threonine Kinases polo-like kinase 1
Topics	Animals Antineoplastic Agents (pharmacology) Apoptosis Cell Cycle Proteins (chemistry) Cell Line, Tumor Cell Proliferation Cell Separation Drug Delivery Systems Flow Cytometry HeLa Cells Humans Male Mice Mice, Inbred BALB C Mitosis Models, Chemical Neoplasm Transplantation Neoplasms (diagnosis, metabolism, pathology) Peptides (chemistry) Positron-Emission Tomography (methods) Protein Serine-Threonine Kinases (chemistry) Protein Structure, Tertiary Proto-Oncogene Proteins (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!